Differential influences of Fc gamma receptor blocking on the effects of certolizumab pegol and infliximab on human monocytes.

Hoshiyama, Takayuki; Matsueda, Yu; Tono, Toshihiro; Arinuma, Yoshiyuki; Nagai, Tatsuo; Hirohata, Shunsei

Hoshiyama, Takayuki; Matsueda, Yu; Tono, Toshihiro; Arinuma, Yoshiyuki; Nagai, Tatsuo; Hirohata, Shunsei.

Afiliação

Hoshiyama T; a Department of Rheumatology and Infectious Diseases , Kitasato University School of Medicine , Sagamihara , Kanagawa , Japan.
Matsueda Y; a Department of Rheumatology and Infectious Diseases , Kitasato University School of Medicine , Sagamihara , Kanagawa , Japan.
Tono T; b Department of Internal Medicine , Kawasaki Municipal Hospital , Kawasaki , Kanagawa , Japan.
Arinuma Y; c Center for Autoimmune and Musculoskeletal Disease , The Feinstein Institute for Medical Research , Manhasset , NY , USA.
Nagai T; a Department of Rheumatology and Infectious Diseases , Kitasato University School of Medicine , Sagamihara , Kanagawa , Japan.
Hirohata S; a Department of Rheumatology and Infectious Diseases , Kitasato University School of Medicine , Sagamihara , Kanagawa , Japan.

Mod Rheumatol ; 28(3): 506-512, 2018 May.

Article em En | MEDLINE | ID: mdl-28805137

Assuntos

Antirreumáticos/farmacologia; Certolizumab Pegol/farmacologia; Infliximab/farmacologia; Monócitos/efeitos dos fármacos; Receptores de IgG/metabolismo; Células Cultivadas; Humanos

Palavras-chave

Certolizumab pegol; infliximab; monocyte; polyethylene glycol

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Monócitos / Receptores de IgG / Antirreumáticos / Certolizumab Pegol / Infliximab Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google